Class II · ModerateActive recall
SEMAGLUTIDE 9mg (4.5 mg/mL)
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot: AC-017125, Exp. 8/30/2026; AC-017138, AC-017147, AC-017214, AC-017226, AC-017228, Exp. 12/31/2026.
Where it was soldNationwide within the U.S
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Apollo Care, LLC |
| NDC | 71170-822-02 |
Show the full FDA record
| Full product label | SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02 |
| Recalling firm | Apollo Care, LLC |
| Distribution | Nationwide within the U.S |
| Quantity | 24,608 vials. |
| Recall initiated | 2026-07-29 |
| Report date | 2026-08-19 |
| Recall completed | — |
| Recall number | D-0751-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Columbia MO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.